GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Operating Margin %

C21 Investments (XCNQ:CXXI) Operating Margin % : 3.20% (As of Oct. 2023)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. C21 Investments's Operating Income for the three months ended in Oct. 2023 was C$0.30 Mil. C21 Investments's Revenue for the three months ended in Oct. 2023 was C$9.44 Mil. Therefore, C21 Investments's Operating Margin % for the quarter that ended in Oct. 2023 was 3.20%.

The historical rank and industry rank for C21 Investments's Operating Margin % or its related term are showing as below:

XCNQ:CXXI' s Operating Margin % Range Over the Past 10 Years
Min: -446.38   Med: 13.69   Max: 29.58
Current: 1.22


XCNQ:CXXI's Operating Margin % is ranked worse than
64.02% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.385 vs XCNQ:CXXI: 1.22

C21 Investments's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

C21 Investments's Operating Income for the three months ended in Oct. 2023 was C$0.30 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Oct. 2023 was C$0.47 Mil.


C21 Investments Operating Margin % Historical Data

The historical data trend for C21 Investments's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Operating Margin % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -446.38 -3.23 27.61 29.58 13.69

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.10 -9.09 7.21 2.95 3.20

Competitive Comparison of C21 Investments's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Operating Margin % distribution charts can be found below:

* The bar in red indicates where C21 Investments's Operating Margin % falls into.



C21 Investments Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

C21 Investments's Operating Margin % for the fiscal year that ended in Jan. 2023 is calculated as

Operating Margin %=Operating Income (A: Jan. 2023 ) / Revenue (A: Jan. 2023 )
=5.308 / 38.773
=13.69 %

C21 Investments's Operating Margin % for the quarter that ended in Oct. 2023 is calculated as

Operating Margin %=Operating Income (Q: Oct. 2023 ) / Revenue (Q: Oct. 2023 )
=0.302 / 9.437
=3.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


C21 Investments Operating Margin % Related Terms

Thank you for viewing the detailed overview of C21 Investments's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (XCNQ:CXXI) Headlines

No Headlines